opens new tab said on Friday the European Patent ... COVID shot Comirnaty after suing them in 2022 for allegedly copying its mRNA technology. Pfizer and BioNTech have countersued, alleging that ...
MODERNA has won the latest round of its long-running legal battle with Pfizer and its German partner BioNTech over its Covid vaccine. The European Patent Office (EPO) has upheld the validity of one of ...
Moderna MRNA-Q said on Friday the European Patent Office had upheld the validity of one of the company’s key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer PFE-N and BioNTech ...
(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the company said on Friday. “We are pleased to announce that the ...
Synopsys VC Verification IP (VIP) for Fibre Channel is designed to thoroughly verify Fibre Channel designs using both random and directed simulation. The Fibre Channel VIP provides full protocol ...
Moderna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a second product as it seeks to move beyond its reliance on the fading market for Covid-19 shots ...
Pfizer’s shot has also done well, although sales haven’t been as strong as GSK’s. The company reported $515 million in Abrysvo sales in 2023. Moderna plans to compete. It will have to, as declining ...
Moderna plans to compete. It will have to, as declining sales of its popular COVID vaccine have put pressure on the company to deliver growth from other products. Like its COVID shot, mResvia is ...
Doctors believe the treatments - which are custom built for each patient - will herald a new era in cancer care, here MailOnline answers all your questions on the breakthrough jabs.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...
Don't have an account yet? To access the premium content on InsuranceERM, you must first sign in to your account. Not registered? Sign up today for free.